Merck KGAA Rebuilds Its R&D Portfolio, Re-Aligns Into Three Businesses
This article was originally published in The Pink Sheet Daily
Executive Summary
The diversified German company eschews the tightening of focus seen in other European pharmaceutical companies, but does subdivide its business into three units: health care, life sciences and performance materials.